Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-028815
Filing Date
2018-06-15
Accepted
2018-06-15 17:07:06
Documents
1
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3861
  Complete submission text file 0001140361-18-028815.txt   5429
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Issuer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Nova Tina Susan (Reporting) CIK: 0001302605 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37367 | Film No.: 18902901